Open AccessIsatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
Author(s) -
Fredrik Schjesvold,
Paul G. Richardson,
Thierry Facon,
Adrián Alegre,
Andrew Spencer,
Artur Jurczyszyn,
Kazutaka Sunami,
Laurent Frenzel,
ChangKi Min,
Sophie Guillonneau,
Psang Dain Lin,
Solenn Le-Guennec,
Frank Campana,
Helgi van de Velde,
S. Bensfia,
Sara Bringhen
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.279160
Subject(s) - pomalidomide , dexamethasone , multiple myeloma , medicine , subgroup analysis , oncology , refractory (planetary science) , lenalidomide , meta analysis , biology , astrobiology